Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats
Abstract Gadolinium based contrast agents (GBCAs) are widely used in clinical MRI since the mid-1980s. Recently, concerns have been raised that trace amounts of Gadolinium (Gd), detected in brains even long time after GBCA application, may cause yet unrecognized clinical consequences. We therefore a...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/475697f1def341ca8d5a1b8ad2c58eaf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:475697f1def341ca8d5a1b8ad2c58eaf |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:475697f1def341ca8d5a1b8ad2c58eaf2021-12-02T14:01:28ZComprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats10.1038/s41598-020-79374-z2045-2322https://doaj.org/article/475697f1def341ca8d5a1b8ad2c58eaf2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79374-zhttps://doaj.org/toc/2045-2322Abstract Gadolinium based contrast agents (GBCAs) are widely used in clinical MRI since the mid-1980s. Recently, concerns have been raised that trace amounts of Gadolinium (Gd), detected in brains even long time after GBCA application, may cause yet unrecognized clinical consequences. We therefore assessed the behavioral phenotype, neuro-histopathology, and Gd localization after repeated administration of linear (gadodiamide) or macrocyclic (gadobutrol) GBCA in rats. While most behavioral tests revealed no difference between treatment groups, we observed a transient and reversible decrease of the startle reflex after gadodiamide application. Residual Gd in the lateral cerebellar nucleus was neither associated with a general gene expression pathway deregulation nor with neuronal cell loss, but in gadodiamide-treated rats Gd was associated with the perineuronal net protein aggrecan and segregated to high molecular weight fractions. Our behavioral finding together with Gd distribution and speciation support a substance class difference for Gd presence in the brain after GBCA application.Johanna HabermeyerJanina BoykenJulia HarrerFabio CannevaVeronika RatzSandra MoceriJakob AdmardNicolas CasadeiGregor JostTobias BäuerleThomas FrenzelChristoph SchmitzGunnar SchützHubertus PietschStephan von HörstenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-14 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Johanna Habermeyer Janina Boyken Julia Harrer Fabio Canneva Veronika Ratz Sandra Moceri Jakob Admard Nicolas Casadei Gregor Jost Tobias Bäuerle Thomas Frenzel Christoph Schmitz Gunnar Schütz Hubertus Pietsch Stephan von Hörsten Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats |
description |
Abstract Gadolinium based contrast agents (GBCAs) are widely used in clinical MRI since the mid-1980s. Recently, concerns have been raised that trace amounts of Gadolinium (Gd), detected in brains even long time after GBCA application, may cause yet unrecognized clinical consequences. We therefore assessed the behavioral phenotype, neuro-histopathology, and Gd localization after repeated administration of linear (gadodiamide) or macrocyclic (gadobutrol) GBCA in rats. While most behavioral tests revealed no difference between treatment groups, we observed a transient and reversible decrease of the startle reflex after gadodiamide application. Residual Gd in the lateral cerebellar nucleus was neither associated with a general gene expression pathway deregulation nor with neuronal cell loss, but in gadodiamide-treated rats Gd was associated with the perineuronal net protein aggrecan and segregated to high molecular weight fractions. Our behavioral finding together with Gd distribution and speciation support a substance class difference for Gd presence in the brain after GBCA application. |
format |
article |
author |
Johanna Habermeyer Janina Boyken Julia Harrer Fabio Canneva Veronika Ratz Sandra Moceri Jakob Admard Nicolas Casadei Gregor Jost Tobias Bäuerle Thomas Frenzel Christoph Schmitz Gunnar Schütz Hubertus Pietsch Stephan von Hörsten |
author_facet |
Johanna Habermeyer Janina Boyken Julia Harrer Fabio Canneva Veronika Ratz Sandra Moceri Jakob Admard Nicolas Casadei Gregor Jost Tobias Bäuerle Thomas Frenzel Christoph Schmitz Gunnar Schütz Hubertus Pietsch Stephan von Hörsten |
author_sort |
Johanna Habermeyer |
title |
Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats |
title_short |
Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats |
title_full |
Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats |
title_fullStr |
Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats |
title_full_unstemmed |
Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats |
title_sort |
comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/475697f1def341ca8d5a1b8ad2c58eaf |
work_keys_str_mv |
AT johannahabermeyer comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT janinaboyken comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT juliaharrer comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT fabiocanneva comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT veronikaratz comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT sandramoceri comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT jakobadmard comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT nicolascasadei comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT gregorjost comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT tobiasbauerle comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT thomasfrenzel comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT christophschmitz comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT gunnarschutz comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT hubertuspietsch comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats AT stephanvonhorsten comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats |
_version_ |
1718392138595565568 |